State of Wisconsin Investment Board’s CytomX Therapeutics CTMX Stock Holding History

State of Wisconsin Investment Board’s Portfolio CTMX Stock Details CTMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$61.7K	Buy	+13,126	New	+$66.6K	﹤0.01%	2456
2021 Q2	–	Sell	-61,800	Closed	-$478K	–	2087
2021 Q1	$478K	Hold	61,800	–	–	﹤0.01%	1614
2020 Q4	$405K	Sell	61,800 -7,700	-11%	-$55K	﹤0.01%	1595
2020 Q3	$462K	Hold	69,500	–	–	﹤0.01%	1512
2020 Q2	$579K	Hold	69,500	–	–	﹤0.01%	1383
2020 Q1	$533K	Buy	69,500 +2,000	+3%	+$13.9K	﹤0.01%	1334
2019 Q4	$561K	Hold	67,500	–	–	﹤0.01%	1404
2019 Q3	$498K	Buy	67,500 +5,400	+9%	+$53.3K	﹤0.01%	1326
2019 Q2	$697K	Buy	62,100 +1,400	+2%	+$14.7K	﹤0.01%	1240
2019 Q1	$653K	Buy	60,700 +15,100	+33%	+$223K	﹤0.01%	1276
2018 Q4	$689K	Buy	45,600 +6,300	+16%	+$93.5K	﹤0.01%	1234
2018 Q3	$727K	Hold	39,300	–	–	﹤0.01%	1306
2018 Q2	$898K	Buy	39,300 +18,300	+87%	+$467K	﹤0.01%	1206
2018 Q1	$597K	Hold	21,000	–	–	﹤0.01%	1253
2017 Q4	$443K	Hold	21,000	–	–	﹤0.01%	1314
2017 Q3	$382K	Hold	21,000	–	–	﹤0.01%	1345
2017 Q2	$325K	Buy	+21,000	New	+$317K	﹤0.01%	1359

Other funds holding CTMX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State of Wisconsin Investment Board's CTMX Position: Q1 2026 in Review

State of Wisconsin Investment Board opened a new position in CytomX Therapeutics (CTMX) in Q1 2026: 13,126 shares worth $61.7K. The stake represents ﹤0.01% of the portfolio and ranks #2456 among its holdings. This is a return to the name: State of Wisconsin Investment Board previously reported a position in CTMX as recently as Q1 2021.

State of Wisconsin Investment Board first reported a position in CTMX in Q2 2017 and has held it in 17 quarters since. The position peaked at $898K in Q2 2018. 179 funds tracked by Wall St. Rank hold CTMX as of Q1 2026.

State of Wisconsin Investment Board held 13,126 shares of CytomX Therapeutics worth $61.7K as of Q1 2026.
CytomX Therapeutics was a new State of Wisconsin Investment Board position in Q1 2026.
CytomX Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #2456 holding.
State of Wisconsin Investment Board first reported a position in CytomX Therapeutics in Q2 2017 and has held it in 17 quarters since.
State of Wisconsin Investment Board's CytomX Therapeutics position peaked at $898K in Q2 2018.
179 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.